We are international
Donate
• treatment options TEXT SIZE   
novel therapies    back

ASH 2011: Dr. Moreau - Pharmacokinetics (PK) and Pharmacodynamics (PD) of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients with Relapsed Multiple Myeloma: Effects of Subcutaneous Injection Site and Concentration, and Patient Characteristics
Philippe Moreau, MD
University Hospital
Nantes, France
12.06.11

Be the first to comment

 related articles